This compound is an aminoglycoside antibiotic active pharmaceutical ingredient used in pharmaceutical manufacturing. It is a complex, multi-ring molecule containing multiple hydroxyl, amine, and ether groups, produced as a stereochemically defined substance.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 50725-24-1
Amikacin EP Impurity G
pharmaceutical raw material
Amikacin hydrate
pharmaceutical raw material
Amikacin sulfate salt
pharmaceutical raw material
Amikacin
antibiotic active pharmaceutical ingredient
Sisomicin sulfate
pharmaceutical raw material
(3S,4R,6S)-4,6-Diamino-3-[(3-{[(2S)-4-amino-2-hydroxybutanoyl]amino}-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 6-amino-6-deoxy-alpha-D-glycero-hexopyranoside
pharmaceutical raw material
Acetylcarnitine hydrochloride
pharmaceutical raw material
Vortioxetine
pharmaceutical raw material
(2S)-4-amino-N-[(1S,2R,3R,4S,5R)-5-amino-4-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
OTDUEYVCDKBDRQ-PVLUVTDWSA-N
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N